Clinical Trial

AI Driven National Platform for CT cOronary Angiography for clinicaL and industriaL applicatiOns Registry

Study acronym: APOLLO
Recruiting
View on ClinicalTrials.gov →
Summary
The overall aim is to build an AI driven national Platform for CT cOronary angiography for clinicaL and industriaL applicatiOns (APOLLO) for automated anonymization, reporting, Agatston scoring and plaque quantification in CAD. It is a "one-stop" platform spanning diagnosis to clinical management and prognosis, and aid in predicting pharmacotherapy response.
Trial Details
NCT Number NCT05509010
Lead Sponsor National Heart Centre Singapore
Collaborators: Agency for Science, Technology and Research
Conditions CAD, Coronary Artery Disease, Coronary Stenosis, Plaques; Epicardial
Enrollment 8,000 participants
Start Date 2021-10-01
Primary Completion 2027-12 (estimated)
Study Completion 2027-12 (estimated)
Updated on ClinicalTrials.gov 2022-08-19